SCHEMBL7284695

SCHEMBL7284695

CCc1cc(NS(=O)(=O)c2ccc(C)cc2)c(C(=O)O)c(CC)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.51
▸ POLB P06746 1/20 0.51
▸ APEX1 P27695 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ CASP6 P55212 1/20 0.51
▸ CTDSP1 Q9GZU7 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ METAP2 P50579 7/20 0.47
▸ MCL1 Q07820 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ KCNA5 P22460 1/20 0.43
▸ CYP2C9 P11712 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ GFER P55789 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ ACLY P53396 1/20 0.43
▸ HK1 P19367 1/20 0.43
▸ KEAP1 Q14145 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186556 0.88 CYP2C9 (0.51) TDP1POLBRECQLLMNACYP2C9
SCHEMBL3176961 0.87 LMNA (0.55) TDP1RECQLL3MBTL1LMNACYP2C9
SCHEMBL9664772 0.82 ALDH1A1 (0.44) TDP1POLBL3MBTL1LMNACYP2C9
SCHEMBL9662788 0.81 CYP2C9 (0.48) TDP1POLBL3MBTL1LMNACYP2C9
SCHEMBL3263302 0.81 LMNA (0.54) POLBL3MBTL1METAP2MCL1LMNA
SCHEMBL3980105 0.70 METAP2 (0.81) METAP2MCL1LMNAKCNA5CYP2C9
SCHEMBL16949985 0.70 ALDH1A1 (0.44) POLBL3MBTL1ALDH1A1CYP1A2MEN1
SCHEMBL3177473 0.69 LMNA (0.58) RECQLLMNACYP2C9ALDH1A1GAA
SCHEMBL12200962 0.69 POLB (0.60) TDP1POLBAPEX1RECQLCASP6
SCHEMBL3180328 0.69 ALDH1A1 (0.52) TDP1POLBAPEX1RECQLCASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0516392-B1 Naphthyridine derivatives as angiotensin II inhibitors ASTRAZENECA AB (SE) 2001-08-29 — — EP disclosed
US-5294620-A Hypotensive agents or compounds for cardiovascular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-03-15 — — US disclosed
WO-1993024501-A1 PHOSPHORUS CONTAINING HETEROCYCLIC COMPOUNDS AS ANGIOTENSINS ANTAGONISTS ZENECA LIMITED (GB) 1993-12-09 — — WO disclosed
WO-1993024487-A1 NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS AS ANGIOTENSIN-II-ANTAGONISTS ZENECA LIMITED (GB) 1993-12-09 — — WO disclosed
US-5217976-A Hypotensive agents, congestive heart failure IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-06-08 — — US disclosed
EP-0516392-A2 Naphthyridine derivatives as angiotensin II inhibitors ZENECA LIMITED (GB) 1992-12-02 — — EP disclosed
Send feedback